Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Wiener Klinische Wochenschrift

• Publication date

  2000-02-11

• Fields of study

  Medicine

• Identifiers
  PMID 10729963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LDL‐apheresis significantly reduces urinary apo(a) excretion

  1997cited by this paper
• Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation.

  1997cited by this paper
• Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

  1996cited by this paper
• Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine.

  1996cited by this paper
• Lipoprotein(a) in renal disease.

  1996cited by this paper
• Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a].

  1996cited by this paper
• Urinary excretion of apo(a) fragments. Role in apo(a) catabolism.

  1996cited by this paper
• Lipoprotein (a) and coronary heart disease.

  1995cited by this paper
• Effect of somatostatin on kidney function and vasoactive hormone systems in healthy subjects

  1991cited by this paper
• Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation.

  1989cited by this paper
• HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

  1989cited by this paper
• Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects.

  1987cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• Lipoprotein Lp(a) and the risk for myocardial infarction.

  1981cited by this paper
• Turnover of lipoprotein (a) in man.

  1980cited by this paper
• Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B.

  1979cited by this paper
• Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease

  1974cited by this paper

• Recent advances in demystifying the metabolism of lipoprotein(a).

  2022cites this paper
• Lipoprotein(a): Structure, Metabolism, and Pathophysiology

  2014cites this paper
• Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.

  2002cites this paper
• Lipoprotein(a): still an enigma?

  2002cites this paper